Merck’s Keytruda reduced the risk of death by 38% for patients with RCC
Keynote -564 is the first Phase 3 trial to demonstrate superior overall survival (OS) with adjuvant therapy compared to placebo in patients with RCC
Keynote -564 is the first Phase 3 trial to demonstrate superior overall survival (OS) with adjuvant therapy compared to placebo in patients with RCC
Dr. Mandaviya also laid the foundation stone for an All India Institute of Speech and Hearing (AIISH) Satellite Centre in Kanpur
Collaboration streamlines patient access to oncology clinical trials
India’s First Integrated Ayush Wellness Centre to come up in Guwahati, foundation stone laid
Lays foundation stone of NIPER Hyderabad and NIPER Raebareli
The workshop was conducted as a part of the NITI–State workshop series
Lays Foundation Stone of 6 new facilities at AIIMS Bhopal and inaugurates a slew of facilities in Madhya Pradesh
Medway setup a state-of-the-art Heart Institute in Chennai
NEIAFMR to be developed as the national hub for folk medicine
If approved, Xolair would be the first medicine to reduce allergic reactions to multiple foods following an accidental exposure
Subscribe To Our Newsletter & Stay Updated